Description

---

A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide can help lawyers find their way through the biotech maze. Leading experts in specialties such as patents, company formation, finance, federal regulation of research through funding, FDA regulation of biomedical research, approval of products for human use, privacy issues, litigation issues and more, will shed some light on this complex subject.

About the Author

---

Hugh Wellons, of Roanoke, VA., focuses his practice on biotechnology and financial law, including corporate law, securities law, and mergers and acquisitions.Hugh is former chair of the ABA Biotechnology Committee and is current joint chair of the Life Sciences division of the ABA's Science and Technology Section. Robert F. Copple, of Scottsdale, AZ., consults with major corporations on complex litigation, intellectual property, crisis management, government relations, and regulatory matters. He is also a trained mediator specializing in technology and environmental disputes. Bill Wofford, of Raleigh, NC., is a partner and member of the Executive Committee of Hutchison Law Group, a Raleigh-based law firm focused on serving the business and intellectual property needs of life sciences and technology companies.